Notice of Redemption and Cancellation of Listing

Source: RNS
RNS Number : 8101M
Bank of America Corporation
25 May 2022

Notice of Redemption and Cancellation of Listing


Bank of America Corporation ("Bank of America" or the "Issuer")


The Issuer has today given notice to the holders of the €10,000,000 Fixed Rate Step-Up Callable Notes, due June 2, 2027 (ISIN: XS1241550299; Common Code: 124155029) (the "Notes") issued under its U.S.$65,000,000,000 Euro Medium-Term Note Program that in accordance with Condition 6(c) of the Terms and Conditions of the Notes and paragraph 23 of the Final Terms dated June 2, 2015 in respect of the Notes (the "Final Terms") it will redeem all of the outstanding Notes on June 2, 2022 (the "Redemption Date").


The redemption price for the Notes will be equal to the Optional Redemption Amount of €100,000 per Note of €100,000 Specified Denomination (as specified in the Final Terms) plus accrued and unpaid interest to, but excluding, the Redemption Date (the "Redemption Price"). As the Redemption Date is not a business day, the Redemption Price will be paid on June 6, 2022, which is the business day that is next succeeding the Redemption Date, with the same force and effect as if such amount were paid on the Redemption Date, and no interest will accrue on the amount so payable for the period from the Redemption Date to such next succeeding business day.


Bank of America will request the Financial Conduct Authority (the "FCA") to cancel the listing of the Notes on the Official List of the FCA and the London Stock Exchange (the "Exchange") to cancel the admission to trading on the regulated market of the Exchange as soon as practicable after the Redemption Date.


A copy of the notice has been submitted to the National Storage Mechanism and will shortly be available for inspection at


For further information please contact:


Lee McEntire, Bank of America, 1.980.388.6780




Jonathan G. Blum, Bank of America (Fixed Income), 1.212.449.3112



Forward-looking statements

Certain information contained in this news release may constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are not guarantees of future results or performance and involve certain risks, uncertainties and assumptions difficult to predict or beyond the Issuer's control. You should not place undue reliance on any forward-looking statement and should consider the uncertainties and risks discussed under Item 1A. "Risk Factors" in the Issuer's Annual Report on Form 10-K for the year ended December 31, 2021, and in any of the Issuer's subsequent U.S. Securities and Exchange Commission filings.  Forward-looking statements speak only as of the date they are made, and the Issuer undertakes no obligation to update any forward-looking statement to reflect the impact of circumstances or events that arise after the date the forward-looking statement was made.




Please note that the information contained in the notice may be addressed to and/or targeted at persons who are residents of particular countries only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the notice is not addressed.  Prior to relying on the information contained in the notice, you must ascertain from the Base Prospectus whether or not you are part of the intended addressees of the information contained therein.


Your right to access this service is conditional upon complying with the above requirements.


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact or visit

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.